A potential coronavirus vaccine being produced by manufacturer Moderna will move to its final testing phase this week, with 30,000 test subjects to be exposed to the treatment, The Associated Press reported. There is no guarantee that it will work.
Across the world, multiple universities, governments, and drug manufacturers are working to get a vaccine against the deadly pathogen up and running, while the COVID-19 pandemic rages, having already killed half a million people worldwide, 149,000 of those in the United States, according to Worldometers.
In the U.S., the manufacturer Moderna has been working in partnership with the National Institutes of Health, to get their own vaccine developed and deployed. To that end, they’ve developed mRNA-1273.
So far, the medicine has been through two small-scale clinical trials — Phase 1 and Phase 2 — and, according to a National Institutes of Health report, was found to be “safe, generally well-tolerated and able to induce antibodies with high levels of virus-neutralizing activity” in test subjects.
0 comments :
Post a Comment